TherapeuticsMD Inc (NYSE MKT LLC:TXMD)
| 4.64 Data as of Jul 25 |  -0.16 / -3.33%Today’s Change | 2.03 Today|||52-Week Range 9.01 | -10.94% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2010 | 2011 | 2012 | 2013 | |||
| Revenue and Income | Net Revenues | 48.2K | 2.1M | 3.8M | 8.8M | |
| Cost of Goods Sold | 71.9K | 947.1K | 1.3M | 2.0M | ||
| Depreciation And Amortization | 61.4K | 54.8K | 56.3K | 58.1K | ||
| Operating Expenses | Gross Income | -85.1K | 1.1M | 2.4M | 6.8M | |
| General Expenses | 382.9K | 6.5M | 18.6M | 32.8M | ||
| Research And Development | -- | 107.2K | 4.5M | 13.6M | ||
| Total Operating Expenses | 516.2K | 7.5M | 20.0M | 34.8M | ||
| Non-Operating Expenses | Operating Income | -468.0K | -5.4M | -16.1M | -26.1M | |
| Extraordinary Credit | 0.00 | 0.00 | 0.00 | 250.0K | ||
| Extraordinary Charge | 0.00 | -7.4M | -17.0M | 0.00 | ||
| Interest Expense On Debt | 64.1K | 64.4K | 2.0M | 2.7M | ||
| Other Expenses | 22.1K | -31.8K | 3.0K | 34.5K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -509.9K | -12.9M | -35.1M | -28.4M | |
| Discontinued Operations | -445.2K | 0.00 | 0.00 | 0.00 | ||
| Extraordinary Items | 259.7K | 0.00 | 0.00 | 0.00 | ||
| Net Income | -955.1K | -12.9M | -35.1M | -28.4M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 164.2K | 62.5M | 91.6M | 127.6M | |
| Shares To Calculate EPS Diluted | 164.2K | 62.5M | 91.6M | 127.6M | ||
| Earnings Per Share | EPS | -$4.00 | -$0.21 | -$0.38 | -$0.22 | |
| EPS Diluted | -$6.00 | -$0.21 | -$0.38 | -$0.22 | ||
.
